Cryptotanshinone alleviates immunosuppression in endometriosis by targeting MDSCs through JAK2/STAT3 pathway.

导出 LinkOut

翻译打印收藏纠错

第一作者： Linling,Xie

第一单位： The Third Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Lingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China.

作者： Linling,Xie ^[1] ; Yu,Zhong ^[1] ; Yi,Chen ^[2] ; Yishu,Wang ^[1] ; Peiyi,Xian ^[1] ; Shanjia,Liu ^[1] ; Xiaoyan,Xin ^[3] ; Yanfen,Chen ^[3] ; Yongge,Guan ^[4] ; Kunyin,Li ^[5]

作者单位： The Third Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Lingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China. ^[1] The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China; Lingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China. ^[2] Foshan Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China. ^[3] The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: gyg2011@gzucm.edu.cn. ^[4] The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: lky0303@gzucm.edu.cn. ^[5]

关键词 Cryptotanshinone Endometriosis Immunosuppressive microenvironment JAK2/STAT3 Myeloid-derived suppressor cells